Cleveland Diagnostics Employee Directory
Biotechnology ResearchOhio, United States51-200 Employees
Cleveland Diagnostics is a biotechnology company based in Cleveland, Ohio, focused on diagnostic tools that leverage protein structure. Its IsoClear platform enables the development of diagnostics based on protein structure-based assessment. The company operates in the biotechnology research space, translating protein science into clinically applicable assays. In March 2026, Cleveland Diagnostics launched the IsoPSA test for prostate cancer, which received FDA clearance for use in laboratories nationwide. The development marks a step toward wider adoption of protein-structure-based diagnostics in clinical settings.